Amylyx Pharmaceuticals

AMLXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.537 B

$22.82 -5.66%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$144.7M

Loss-making

Shares outstanding

111,423,048

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#91Nektar TherapeuticsNKTR$2.58B
#92Ultragenyx PharmaceuticalRARE$2.55B
#93Amylyx PharmaceuticalsAMLX$2.54B
#94PharvarisPHVS$2.43B
#95Viridian Therapeutics, Inc.\DEVRDN$2.43B

Where these numbers come from

Share counts and financials for Amylyx Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.